Cellebrite DI Ltd. (CLBT)
(Delayed Data from NSDQ)
$18.06 USD
+0.32 (1.80%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $18.06 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth C Momentum C VGM
Income Statements
Fiscal Year end for Cellebrite DI Ltd falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 325 | 271 | 246 | 0 | 172 |
Cost Of Goods | 53 | 51 | 43 | 0 | 36 |
Gross Profit | 272 | 220 | 204 | 0 | 136 |
Selling & Adminstrative & Depr. & Amort Expenses | 239 | 219 | 190 | 0 | 138 |
Income After Depreciation & Amortization | 33 | 1 | 14 | 0 | -2 |
Non-Operating Income | -109 | 120 | 68 | 0 | 3 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -76 | 121 | 82 | 0 | 1 |
Income Taxes | 6 | 0 | 11 | 0 | 3 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -81 | 121 | 71 | 0 | -2 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -81 | 121 | 71 | 0 | -2 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 42 | 10 | 21 | 0 | 3 |
Depreciation & Amortization (Cash Flow) | 9 | 9 | 7 | 0 | 4 |
Income After Depreciation & Amortization | 33 | 1 | 14 | 0 | -2 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 190.16 | 195.39 | 161.54 | NA | NA |
Diluted EPS Before Non-Recurring Items | 0.18 | 0.03 | 0.20 | NA | NA |
Diluted Net EPS (GAAP) | -0.43 | 0.59 | 0.44 | -0.01 | NA |
Fiscal Year end for Cellebrite DI Ltd falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 95.71 | 89.58 | 93.01 | 84.18 |
Cost Of Goods | NA | 16.26 | 13.26 | 14.92 | 12.88 |
Gross Profit | NA | 79.45 | 76.32 | 78.10 | 71.30 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 66.96 | 67.07 | 63.10 | 57.82 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 12.49 | 9.25 | 15.00 | 13.48 |
Non-Operating Income | NA | -34.50 | -78.58 | -27.34 | -6.63 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -22.02 | -69.33 | -12.35 | 6.85 |
Income Taxes | NA | 1.80 | 2.04 | 2.30 | 0.35 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -23.81 | -71.37 | -14.65 | 6.50 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -23.81 | -71.37 | -14.65 | 6.50 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 198.95 | 196.82 | 194.44 | 204.39 |
Diluted EPS Before Non-Recurring Items | NA | 0.10 | 0.08 | 0.08 | 0.09 |
Diluted Net EPS (GAAP) | NA | -0.12 | -0.36 | -0.08 | 0.03 |